ANTICOAGULATION THERAPY IN THE PACU

Updated 9/25

In the image above, a patient has just arrived
in PACU, following surgical intervention on
her spine. She is also receiving Anticoagulation
 therapy for a past history of Atrial fibrillation.

The patient on Anticoagulation therapy is at risk
for bleeding. This should be reflected in the plan
of care.

Enjoy the video: Anticoagulation therapy

Learn more about : The Nursing Process

Reperfusion Therapy is a form of treatment used
for patients who have a myocardial infarction with 
STEMI ( ST segment elevation myocardial infarction).
See above image for an example of STEMI.

STEMI 

Typically, the patient with a completely blocked
coronary artery, would demonstrate STEMI on 
the EKG. Death of the heart muscle caused by a
blood clot, would obstruct blood flow and cause
lack of oxygen. 

Severe chest pain, shortness of breath and possible
fainting may occur. Quick intervention would be
necessary to prevent further damage. 

TPA

TPA ( Thrombolytic Plasminogen Activator) is
a " clot buster" that is used in the treatment of 
embolic stroke and myocardial infarction with
STEMI. 

TPA  is not without its side effects. Bleeding, 

particularly into the brain and at injection sites,
 seizures and possible anaphylaxis may occur.

Labetolol , an antihypertensive may be ordered.
ICP monitoring may also be ordered by the doctor.

Diabetic Retinopathy

 This condition affects the blood vessels in the eye.
 Poor vision and possible blindness may result from
 leaking and weakening of the blood vessels.

The consequences of poor circulation

The patient who has heart failure,
is also at risk for stroke or renal failure.
The diabetetic patient is also at risk for stroke.